{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:51:46Z","timestamp":1783075906304,"version":"3.54.6"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.braindev.2004.02.010","type":"journal-article","created":{"date-parts":[[2004,4,21]],"date-time":"2004-04-21T08:14:02Z","timestamp":1082535242000},"page":"530-534","source":"Crossref","is-referenced-by-count":70,"title":["A major influence of CYP2C19 genotype on the steady-state concentration of N-desmethylclobazam"],"prefix":"10.1016","volume":"26","author":[{"given":"Kenjiro","family":"Kosaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyo","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazuki","family":"Samejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Tanigawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2004.02.010_BIB1","first-page":"287","article-title":"Time-dependence of clobazam and N-demethylclobazam kinetics in healthy volunteers","volume":"24","author":"Bun","year":"1986","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.braindev.2004.02.010_BIB2","series-title":"Antiepileptic drugs","first-page":"763","article-title":"Benzodiazepines: clobazam","author":"Shorvon","year":"1995"},{"key":"10.1016\/j.braindev.2004.02.010_BIB3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1528-1157.1996.tb00643.x","article-title":"Effects of clobazam and its active metabolite on GABA-activated currents in rat cerebral neurons in culture","volume":"37","author":"Nakamura","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2004.02.010_BIB4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-0773.1990.tb00799.x","article-title":"Effects of age and antiepileptic drugs on plasma levels and kinetics of clobazam and N-desmethylclobazam","volume":"67","author":"Bun","year":"1990","journal-title":"Pharmacol Toxcol"},{"key":"10.1016\/j.braindev.2004.02.010_BIB5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00007691-199208000-00002","article-title":"Interactions between clobazam and standard antiepileptic drugs in patients with epilepsy","volume":"14","author":"Sennoune","year":"1992","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.braindev.2004.02.010_BIB6","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00007691-199912000-00004","article-title":"Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy","volume":"21","author":"Contin","year":"1999","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.braindev.2004.02.010_BIB7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2165\/00003088-199631060-00005","article-title":"Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations","volume":"31","author":"Riva","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.braindev.2004.02.010_BIB8","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/bi00173a017","article-title":"Evidence that CYP2C19 is the major (S)-mephenytoin 4\u2032-hydroxylase in humans","volume":"33","author":"Goldstein","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.braindev.2004.02.010_BIB9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00007691-199007000-00020","article-title":"Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators","volume":"12","author":"Andersson","year":"1990","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.braindev.2004.02.010_BIB10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00007691-200212000-00009","article-title":"Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam","volume":"24","author":"Contin","year":"2002","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.braindev.2004.02.010_BIB11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0387-7604(03)00074-3","article-title":"Unusual side-effects due to clobazam: a case report with genetic study of CYP2C19","volume":"26","author":"Parmeggiani","year":"2003","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2004.02.010_BIB12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.0306-5251.2001.01499.x","article-title":"Clinical relevance of genetic polymorphisms in the human CYP2C subfamily","volume":"52","author":"Goldstein","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.braindev.2004.02.010_BIB13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0300-483X(02)00492-4","article-title":"Polymorphism of cytochrome P450 and xenobiotic toxicity","volume":"181\u2013182","author":"Ingelman-Sundberg","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.braindev.2004.02.010_BIB14","doi-asserted-by":"crossref","first-page":"15419","DOI":"10.1016\/S0021-9258(17)40694-6","article-title":"The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans","volume":"269","author":"de Morais","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.braindev.2004.02.010_BIB15","first-page":"594","article-title":"Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese","volume":"46","author":"de Morais","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.braindev.2004.02.010_BIB16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0378-4347(00)83039-X","article-title":"Capillary gas chromatographic-mass spectrometric method for the identification and quantification of some benzodiazepines and their unconjugated metabolites in plasma","volume":"487","author":"Drouet-Coassolo","year":"1989","journal-title":"J Chromatogr"},{"key":"10.1016\/j.braindev.2004.02.010_BIB17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/abio.2000.4671","article-title":"Polymerase chain reaction-single-strand conformation polymorphism based determination of two major genetic defects responsible for a phenotypic polymorphism of cytochrome P450 (CYP) 2C19 in the Japanese population","volume":"284","author":"Itoh","year":"2000","journal-title":"Anal Biochem"},{"key":"10.1016\/j.braindev.2004.02.010_BIB18","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1210\/jc.87.8.3529","article-title":"PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome","volume":"87","author":"Kosaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"Supplement","key":"10.1016\/j.braindev.2004.02.010_BIB19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2125.1979.tb05920.x","article-title":"Pharmacology of antianxiolytic drugs with special reference to clobazam","volume":"7","author":"Fielding","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.braindev.2004.02.010_BIB20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2125.1987.tb03032.x","article-title":"N-desmethyl-clobazam: a possible alternative to clobazam in the treatment of refractory epilepsy","volume":"23","author":"Haigh","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.braindev.2004.02.010_BIB21","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.7326\/0003-4819-129-12-199812150-00006","article-title":"Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer","volume":"129","author":"Furuta","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.braindev.2004.02.010_BIB22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s002280050703","article-title":"CYP2C19 polymorphism effect on phenobarbitone. Pharmacokinetics in Japanese patients with epilepsy: analysis by population pharmacokinetics","volume":"55","author":"Mamiya","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.braindev.2004.02.010_BIB23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00008571-200212000-00004","article-title":"Identification and functional characterization of new potentially defective alleles of human CYP2C19","volume":"12","author":"Blaisdell","year":"2002","journal-title":"Pharmacogenetics"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760404000622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760404000622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T17:54:21Z","timestamp":1623866061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760404000622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0387760404000622"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2004.02.010","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}